SCHEMBL16626656

SCHEMBL16626656

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Oc3ccc(C(F)(F)F)cc3Cl)ccc12

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 6/20 0.46
HTR2A P28223 5/20 0.46
KCNH2 Q12809 5/20 0.46
MRGPRX4 Q96LA9 1/20 0.37
SLC6A2 P23975 1/20 0.37
HTR6 P50406 2/20 0.37
CYP3A4 P08684 1/20 0.36
CYP3A5 P20815 1/20 0.36
S1PR1 P21453 1/20 0.36
ALPL P05186 1/20 0.36
FFAR1 O14842 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
TTR P02766 1/20 0.35
PPOX P50336 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SCN9A Q15858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16619083 0.99 SLC6A4 (0.45) SLC6A4HTR2AKCNH2MRGPRX4SLC6A2
SCHEMBL17971584 0.90 PDE4A (0.41) SLC6A4HTR2AKCNH2SLC6A2HTR6
SCHEMBL16626794 0.89 LMNA (0.47) HTR6CYP3A4KMT2AMEN1SCN9A
Hydrochloric Acid SCHEMBL16619290 0.88 LMNA (0.46) HTR6CYP3A4KMT2AMEN1SCN9A
SCHEMBL16626751 0.85 CYP3A4 (0.37) SLC6A4HTR2AKCNH2SLC6A2HTR6
Hydrochloric Acid SCHEMBL16618893 0.84 CYP3A4 (0.37) SLC6A4SLC6A2HTR6CYP3A4CYP3A5
SCHEMBL16626431 0.83 NAMPT (0.38) HTR6CYP3A4CYP3A5S1PR1KMT2A
Hydrochloric Acid SCHEMBL16618827 0.82 NAMPT (0.37) HTR6CYP3A4CYP3A5S1PR1KMT2A
SCHEMBL19984236 0.82 SLC6A4 (0.46) SLC6A4HTR2AKCNH2MRGPRX4SLC6A2
SCHEMBL17971585 0.81 HTR6 (0.40) HTR6SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI SLC6A4 1266/4885HTR2A 218/4885KCNH2 4211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.